Live feed
Filing
SC 13D/A
SC 13D/A0001144204-19-000921·MORGENTHALER VENTURE PARTNERS IX LP
Schedule 13D ownership disclosure
Ra Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74933V108
Event date: 2019-01-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,261,533
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-000921
- Form type
- SC 13D/A
- Filer
- MORGENTHALER VENTURE PARTNERS IX LP
- CIK
- CIK 1439101
- Filed
- Jan 07, 2019
- Reporting period
- Jan 04, 2019
- Description
- Schedule 13D beneficial ownership